Grant of Options

RNS Number : 3933S

Synairgen plc

09 September 2010

 



9 September 2010

Synairgen plc ('Synairgen' or the 'Company')

Grant of options

On 8 September 2010 Richard Marsden, Chief Executive Officer of Synairgen, was granted options over 498,969 ordinary shares of 1 pence each ("Ordinary Shares") in the Company under the Company's Long-Term Incentive Plan (the "LTIP") at an exercise price of 1 pence per share.

Mr Marsden's holding in options over Ordinary Shares has therefore increased to 2,098,822, representing approximately 3.51 per cent. of the issued ordinary share capital of the Company.

On 8 September 2010 John Ward, Finance Director of Synairgen, was granted options over 453,608 Ordinary Shares in the Company under the Company's LTIP at an exercise price of 1 pence per share.

Mr Ward's holding in options over Ordinary Shares has therefore increased to 1,551,656, representing approximately 2.60 per cent. of the issued ordinary share capital of the Company.

On 8 September 2010 Dr Phillip Monk, Chief Scientific Officer of Synairgen, was granted options over 371,134 Ordinary Shares in the Company under the Company's LTIP at an exercise price of 1 pence per share.

Dr Monk's holding in options over Ordinary Shares has therefore increased to 925,198, representing approximately 1.55 per cent. of the issued ordinary share capital of the Company.

For further information, please contact:

Synairgen plc                                                            Tel: + 44 (0) 23 8051 2800

Richard Marsden, Chief Executive Officer

John Ward, Finance Director

Matrix Corporate Capital                                         Tel: + 44 (0) 20 3206 7000

Alastair Stratton

Steven Cox 

 

END

 

 

IOEEAENPEDNEEAF